Literature DB >> 991164

A protective effect of verapamil on hypoxic heart muscle.

W G Nayler, A Grau, A Slade.   

Abstract

Hypoxic-induced damage of rabbit heart muscle has been quantitated in terms of the release of intracellular enzymes (including creating phosphokinase, CPK) into the extracellular space, a gain in tissue Na+ and Ca2+, a loss of tissue K+, the depletion of the adenosine triphosphate (ATP) and creatine phosphate (CP) reserves, and ultrastructural damage. This ultrastructural damage incolves the disruption of the plasmalemma, swelling and distortion of the mitochondria, disruption of the myofilaments, and the development of contraction bands. In isolated Langendorff-perfused rabbit hearts perfused under either aerobie (pO2 greater than 80.0 kPa [600 mm Hg]) or hypoxie (pO2 less than 0.80 kPa [6 mmHg]) conditions, and either with or without glucose substrate, 0.5-1.0 mg/litre dl verapamil reduced the amount of ultrastructural damage caused by hypoxie perfusion. Verapamil (0.5-1.0 mg/litre) also reduced the rate at which the hypoxie muscle gained Na+ and lost K+; it reduced the rate at which the endogenous stores of ATP and CP were depleted and, provided that the extracellular phase contained Ca2+, it decreased the rate at which CPK appeared in the coronary effluent. Verapamil failed to prevent the hypoxie muscle from gaining Ca2+. These results are discussed in terms of a possible protective effect of dl verapamil on hypoxie heart muscle.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991164     DOI: 10.1093/cvr/10.6.650

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  29 in total

1.  Combined effect of glucose and verapamil in experimental cardioplegia.

Authors:  E Hochhauser; Y Barak; S Einav; S Cohen; B Vidne
Journal:  Tex Heart Inst J       Date:  1986-03

2.  The effect of substance P on cyclic AMP and cyclic GMP levels in actively secreting pancreatic lobules [proceedings].

Authors:  J Albano; K D Bhoola; R F Harvey
Journal:  J Physiol       Date:  1978-02       Impact factor: 5.182

3.  Effects of the calcium antagonist gallopamil on the increase of myocardial extracellular potassium activity during LAD occlusion in dogs.

Authors:  M Budden; M Kirchengast; K M Zhang; W Meesmann
Journal:  Basic Res Cardiol       Date:  1987 May-Jun       Impact factor: 17.165

4.  Effect of prolonged beta-adrenoceptor blockade on heart weight and ultrastructure in young rabbits.

Authors:  W G Nayler; A Slade; E M Vaughan Williams; C E Yepez
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

5.  Correlative studies on sarcolemmal ultrastructure, permeability, and loss of intracellular enzymes in the isolated heart perfused with calcium-free medium.

Authors:  M Ashraf
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

Review 6.  Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 7.  Calcium antagonists: definition and mode of action.

Authors:  W G Nayler; P Poole-Wilson
Journal:  Basic Res Cardiol       Date:  1981 Jan-Feb       Impact factor: 17.165

8.  Systematic variations in the content of the purine nucleotides in the steady-state perfused rat heart. Evidence for the existence of controlled storage and release of adenine nucleotides.

Authors:  D J Bates; D Perrett; J Mowbray
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

Review 9.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

10.  Diastolic tension of rat cardiac muscle during deficiency of oxygen and glucose. Stress-strain relationships and reversibility.

Authors:  C Holubarsch; R Jacob
Journal:  Basic Res Cardiol       Date:  1981 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.